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ABSTRACT 
Reactive oxygen species (ROS) have been known to cause 
damage to a variety of biological substances especially DNA. 
The most reactive of the ROS are the hydroxyl radicals (*0H) 
which, can attack virtually any target molecule it 
encounters. These are formed in biological systems via 
ionizing radiations or through the Fenton reaction. The 
hydroxyl radical may attack DNA at either the sugar or the 
base, ultimately causing DNA single stranded breaks and 
formation of altered bases. It has been implicated in a 
number of human diseases as the causative agent, parti-
cularly in the induction and development of cancer. 
In earlier studies hydroxyl radical was generated by 
exposure of hydrogen peroxide to 254 nm light in the 
presence of native calf thymus DNA, which resulted in single 
strand breaks, decrease in melting temperature and 
structural alteration of purine and pyrimidine bases. The 
hydroxyl radical modified DNA was found to be highly 
immunogenic inducing antibodies which showed binding to 
native B-conformation. The antibodies induced by ROS-DNA 
were also found to recognise A- and allied conformations of 
deoxyribonucleic acid, thus exhibiting polynucleotide 
specificity. Moreover, naturally occurring human anti-DNA 
autoantibodies showed enhanced recognition of ROS-modified 
DNA as compared to the unmodified polymer. 
In the present study, DNA bases adenine and thymine and 
the synthetic polymers poly (dA) and poly (dT) were modified 
by 254 nm light in the presence of hydrogen peroxide. As a 
consequence of modification, adenine and thymine showed 
drastic changes in their UV absorption profile, while homo-
polymers poly (dA) and poly (dT) showed substantial decrease 
in UV absorbance at 260 nm. The ROS-modified bases and 
polymers were used as inhibitors of native DNA binding to 
human anti-DNA autoantibodies. Maximum percent inhibition 
was obtained with ROS-thymine and to a lesser extent with 
poly (dT) and ROS-poly (dT) . However, adenine and poly (dA) 
and their modified products did not show any apparent 
inhibition. 
Native DNA is a poor immunogen. DNA modified with 
chemical and physical agents appears to be the most likely 
candidate for the production of human anti-DNA autoanti-
bodies. One such species is hydroxyl radical, the most 
reactive of all known oxygen species which reacts with very 
high rate constants with most of the molecules in a cell. 
The formation of hydrogen peroxide and thus hydroxyl 
radicals is increased considerably in several pathological 
conditions and exposure to radiant energy. It could thus be 
concluded from this study that thymine upon interaction with 
hydroxyl radical is modified inducing conformational changes 
in DNA, which could trigger the production of circulating 
antibodies cross reacting with native DNA. 
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1. INTRODUCTION 
Deoxyribonucleic acid in its native form is a double 
stranded polymer formed of two helical polynucleotide chains 
coiled around a common axis. It consist of the purine and 
pyrimidine bases and the structure is referred as B-DNA. The 
polymer can also assume other helical forms, such as A-DNA, 
Z-DNA etc. These different conformations are in equilibrium 
with each other (Dickerson et al., 1982; Kennard, 1983; Rich 
et al., 1984; Pechenaya, 1993). The genetic information of 
the DNA molecule is contained in its bases, while the sugar 
and phosphate perform a structural role. The four bases i.e. 
adenine and guanine (purines) , cytosine and thymine 
(pyrimidines) are depicted in Fig. 1. 
As regards the immunogenicity of nucleic acids, it has 
been found that although most nucleic acids are 
immunogenic, double stranded DNA of the B-conformation is 
not (Stollar, 1986). However, chemically modified DNA is 
usually immunogenic. In the first experimental evidence on 
phage T^ DNA, antibodies directed to the modified bases of 
the phage appeared (Levine et al. , 1960). Later on, 
experiments conducted showed the importance of modified 
bases for both immunogenicity and specificity (Gruenewald 
and Stollar, 1973) . 
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Figure 1. Structure of the common nitrogenous bases of 
DNA 
Hydrogen Peroxide Induced Cytotoxicity 
There has been increasing interest in the molecular 
mechanisms involved in the cytotoxic action of hydrogen 
peroxide in the recent years (Cantoni et al., 1989) . It is a 
normal metabolite in aerobic cells, formed by divalent 
reduction of dioxygen or by dismutation of the superoxide 
anion ^adical, fO^  ) (Tachon, 1989). In celJular steady 
state, the concentration of hydrogen peroxide is in the 
range of 10"^ - 10"^ M (Oshino et al., 1973). However, its 
production can be increased under several pathological 
conditions, especially at the site of inflammation where the 
oxidative burst of the phagocytic cell occurs (Hammers and 
Roos, 1985) and upon irradiation with near ultraviolet light 
or visible light (Hoffman and Meneghini, 1979) and ionizing 
radiation (Hart, 1972). 
Hydrogen peroxide however, is a relatively stable 
oxidant and does not per se cause DNA damage. In intact 
cells, it is the precursor of a much more damaging reactant 
(Repine et al., 1981). This reactant may be the hydroxyl 
radical"OH, which is so reactive that it can only diffuse 5-
10 molecular diameters before it reacts (Pryor, 1988). So, 
if it is not produced near DNA, it probably will not react 
with it. The chemical process that produces it can be 
expressed as the Haber-Weiss reaction (Haber and Weiss, 
1934) . 
H2O2 + 02 >'0H + OH + O2 
The reaction is thermodynamically feasible, but 
kinetically very slow unless certain transition metals are 
present (Halliwell, 1978; McCord and Day, 1978). Iron is an 
excellent catalyst and through its mediation the above 
reaction can be written as a sum of two other reactions. 
O2 + Fe^ "^  > Fe^ "^  + O2 
Fe^ "^  + H2O2 -> Fe^ "*" + OH + OH" 
O2 + H2O2 > '0H + OH" + O2 
This reaction has been known for a long time and is 
referred to as the Fenton reaction (Fenton, 1893). Other 
transition metals like copper and cobalt can also drive a 
Fenton reaction ( Gutteridge and Halliwell, 1982; Moorhouse 
et al., 1985; Goldstein and Czapski, 1986; Nackerdien et 
al., 1991). 
Cu"^  + H2O2 > Cu^ "^  + OH + OH' 
It is however not clear whether this last reaction can 
occur in the cell since it has been shown that free copper 
ions are not available and protein-bound copper ions are 
unable to catalyze the formation of 'OH (Rowley and 
Halliwell, 1983) . It has been shown that Cu^ "^  and H2O2 or 
Fe^ "^  and H2O2 - catalyzed DNA damage was very slow and 
required the presence of a reducing agent such as ascorbate 
(Stoewe and Prlitz. 1987) or NADPH (Imlay and Linn, 1988) . 
Antioxidants and Hydroxyl Radical Scavengers 
The accumulation of the reactive oxygen species (ROS) 
would be deleterious to the cell and has to be prevented. 
Living systems have defensive mechanisms to overcome this, 
such as superoxide dismutase catalysed inactivation of 0*^  
(Fridovich, 1978; Halliwell and Guttteridge, 1986) and 
2H'^  + 2O2 > H2O2 + O2 
catalase and peroxidase for Hydrogen peroxide 
catalase 
2H2O2 > 2H2O + O2 
glutathione 
H2O2 + 2 GSH > G-S-S-R + 2 H2O 
peroxidase 
Lidocaine, a local anaesthetic has been found to be a 
potent scavenger of hydroxyl radicals and singlet oxygen 
(Das and Misra, 1992) . Other antioxidants such as ascorbic 
acid and vitamin E may also play a critical role against 
oxidative damage. Recently, potent antioxidant activities of 
pteridines, particularly the reduced form of neopterin have 
been demonstrated (Icho et al. , 1993) which have been 
further confirmed by Weiss et al (1993). According to 
Fridovich (1977), oxygen toxicity is normally held in check 
by a balance among the rates of formation and destruction of 
reactive forms of oxygen. Thus, the deleterious effects of 
H2O2 can be kept in check by both iron chelators and 
hydroxyl radical scavengers (Mello-Filho et al. , 1984; 
Mello- Filho and Meneghini, 1984). 
Relatively recently, thioctic acid (or lipoic acid) 
and its reduced form dihydrolipoic acid have gained 
recognition as useful biological antioxidants, particularly 
in their ability to inhibit lipid peroxidation (Suzuki et 
al., 1991). 
ROS and DNA Damage 
The role of H2O2 in the production of genetic damage 
has been known for more than twenty years now (Rhaese and 
Freese, 1968; Schweitz, 1969; Massie et al., 1972). It has 
been suggested that H2O2 mediated DNA damage occurs at the 
site where the reduced metal is bound to the DNA (Czapski, 
1984). Hydroxyl radical may attack DNA at either the sugar 
or the base (Hutchinson, 1985), ultimately causing DNA 
strand breaks. The mechanism of single strand breaks 
involves addition of *0H to C = C of the base or abstraction 
of H atoms from the various positions of sugar moiety 
(Schulte - Frohlinde and Von Sonntag, 1985). 
It has been reported that UV light exposure gives rise 
to free radical formation in human skin (Pathak and 
Stratton, 1968). Photo-lesions are induced in DNA on direct 
absorption of UV radiation. The best characterized lesions 
are those induced by UV-C (190-280 nm) , especially at 254 
nm, which is close to the absorption maxima of DNA. One type 
of damage has been shown to be the formation of pyrimidine 
cyclobutane dimer (Sage, 1993). Melanin has a number of 
unusual properties and is quite photo-reactive (Hubbard-
Smith et al. , 1992). When it is UV irradiated, the 
generation of superoxide anion radical ('O2 ) hydrogen 
peroxide and hydroxyl radical ("OH ) has been observed 
(Korytowski et al., 1987). Melanin can also scavenge major 
radicals. 
Ionizing radiations predominantly cause formation of 
nucleoside hydroperoxides in DNA, particularly susceptible 
is thymine (Scholes, 1983; Simic and Jovanovic, 1986) . Their 
decomposition generates more stable products and active 
oxygen species which may oxidize other DNA bases (Tofigh and 
Frenkel, 1989). Recently, a number of modified bases have 
been isolated from chromatin of Y^  - irradiated human cells. 
These are cytosine glycol, thymine glycol, 8 hydro-
xyadenine, 2-hydroxyadenine and 8-hydroxyguanine (Nackerdien 
et al., 1992). DNA containing thymine glycol adducts in 
Deinococcus radiodurans have been cleaved by DNA deoxy-
ribophospho diesterase (Mun et al., 1994). 
Role of ROS in Diseases 
The role of oxygen free radicals has been implicated in 
a variety of pathophysiological conditions including aging, 
cancer, diabetes, heart disease and various neurological 
disorders (Freeman and Crapo, 1982; Halliwell and 
Gutteridge, 1985). There is reasonable evidence to suggest a 
possible role of free radicals in initiation of 
carcinogenesis. It is believed that tumor promoters commonly 
exert their effect through the synthesis of oxygen radicals 
(Ames, 1983; Sun, 1990). The possible role of anti-oxidants 
in protecting the human body against cancer has been better 
understood by a massive research effort over the last decade 
(Byers and Perry, 1992) . Most important of these are the 
carotenoids, Vitamin C and vitamin E, which may protect 
against cancer by several mechanisms (Henson et al., 1991; 
Knekt et al., 1991). 
Reactive oxygen species (ROS) play an important role in 
the killing of many microorganisms by mononuclear phagocytes 
and neutrophils (Segal, 1989) . Although data are discrepan , 
several studies have suggested that the generation of 
reactive oxygen intermediates (ROD is impaired in 
mononuclear phagocytes and possibly also in neutrophils from 
HIV-infected individuals, leading to deficient killing of 
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intracellular microorganisms, predisposing the HIV-infected 
patients to various opportunistic infections. Thus 
suggesting the possible role of ROI in iramunopathogenesis of 
HIV infection (Muller, 1992) . 
Auto inmuni ty 
Immune system can noinnally distinguish or discriminate 
between self and non-self and mount an immunologic attack 
directed against agents which are foreign or non-self. 
However, when an immunological disbalance occurs, the 
individual's own tissue components may become participants 
in immunologic reactions and injury, resulting in clinical 
disease (Deodhar, 1992) . Thus, autoimmunity can be defined 
by the presence of autoantibodies and/or T cells which react 
against self antigens (Druet, 1992). 
It was proposed in 1974 by Jerne that immunologic 
regulation is mediated by an idiotype - anti-idiotype 
network. Idiotypes are the unique structural moieties in the 
variable portions of a given antibody molecule that are 
capable of serving as immunogens in a given individual. 
Thus, an immune response to such idiotypes results in the 
formation of anti-idiotypic antibodies. These can, in turn 
bind with the respective idiotypes in the varible region of 
a given antibody, thus blocking its pathogenic effect. 
Etiology o£ Autoimmune Disease 
There is no single theory or mechanism that can 
adequately explain all features of autoimmune diseases. Many 
theories have been postulated to explain the immune 
responses against host antigens, which could be due to 
genetic factors, exaggerated random B cell activity, cross 
reactivity between host and foreign antigens or modification 
of host proteins due to infection, drug administration, 
inflammation etc. (Theofilopoulos and Dixon, 1985; Huang et 
al., 1988). 
(a) Role of genetic factors 
Autoimmune diseases in general show a highly 
significant familial predisposition. Relatives of patients 
with a given autoimmune disease are known to be at high risk 
for developing the same disease and the relevant auto-
antibodies are known to occur in a much higher frequency 
among patients' relatives than in general population 
(Hochberg, 1987; Arnett, 1992). This involvement of genetic 
factors has been linked to the human lymphocyte antigen 
(HLA) system particularly the HLA-DR sublocus. The HLA genes 
function as secondary genes to allow expression of specific 
autoantibody or the respective disease state (Bias et al., 
1986) . 
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(b) T-helper/T-suppressor cell imbalance 
The immune response is controlled mainly by the 
regulatory influence of T-lymphocyte subsets, T-helper and 
T-suppressor cells. In normal individuals, the ratio of T-
helper to T-suppressor cells in peripheral blood tends to be 
approximately 2 : 1, whereas in almost all of the auto-
immune diseases studied so far, this ratio is considerably 
greater, often approaching 10 or 15 : 1, particularly during 
the acute or active phase of the disease (Morimoto et al., 
1987; Shivakumar et al., 1989). In most cases there is a 
significant decrease in T-suppressor cells number and 
activity and this accounts for the increased T-helper/T-
suppressor ratio. 
(c) Hormonal factors 
It is well known that autoimmune diseases occur far 
more commonly in females than they do in males, with the 
ratio of female to male involvement often reaching 10 : 1 or 
greater in certain diseases (Talal, 1979). There is evidence 
to support the hypothesis that sex related factors are 
involved in the pathogenesis of SLE (Talal, 1989; Carlsten 
et al., 1990; Counihan et al., 1991; Lahita, 1992). It has 
been reported that testosterone and thymic hormones enhance 
CD8+ T cell receptor function (Lahita and Kunkel, 1984), 
whereas estrogen may suppress this function (Talal and 
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Ahmad, 1987) . Also, female relatives of patients with 
certain autoimmune diseases have been reported to 
deomonstrate a significant prevalence of autoantibodies and 
suppressor T cell defects (Miller and Schwartz, 1982). 
(d) Polyclonal B cell activation 
Polyclonal B-cell activation may be one possible 
mechanism responsible for the over-activation of B cells and 
production of autoantibodies in certain autoimmune diseases, 
particularly SLE (Dziarski, 1988; Klinman et al., 1990; 
Steinberg, 1992) . B cell hyper-responsiveness and spontane-
ous polyclonal activation are invariably present in both SLE 
patients and animal models of SLE (Theofilopoulos and Dixon, 
1985). The sequence of events is believed to be as follows -
in autoimmune prone individuals, B cells are hyper-
responsive to polyclonal activators and undergo initial 
activation, followed by expansion, inlcuding expansion of 
autoreactive clones, under the influence of exogenous or 
endogenous polyclonal activators. 
Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is a multisystem 
autoimmune disease (Isenberg and Shoenfeld, 1987) of unknown 
etiology, characterized by the presence of autoantibodies in 
circulation that bind to numerous self antigens. The anti-
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DNA antibodies in the sera of patients with SLE are of 
diverse antigenic specificities (Pollard et al., 1986; Ali 
et al. , 1991), which inlcude components of DNA, its 
different conformations including modified structures (Hasan 
et al., 1991; Alam and Ali, 1992;). Both right handed (A-
form) and left handed (Z-form) polymers are potentially 
immunogenic (Nakazato, 1980; Stollar, 1986). Also, 
antibodies to double stranded RNA or RNA-DNA hybrids have 
been detected (Talal et al., 1971). In contrast, unmodified 
B-DNA is a poor immunogen and antibodies are rarely induced 
by deliberate immunization (Stollar, 1973). However, 
antibodies that react with B-conformation (native) of DNA 
are found in patients with SLE (Stollar, 1989) . It has been 
suggested that chemically modified DNA results in the 
production of antibodies directed towards the modified 
structure (Zouali et al., 1988). Also, naturally occurring 
anti-DNA antibodies show increased binding to DNA modified 
with reactive oxygen species (ROS) when compared with native 
antigen (Blount et al. , 1990). The antibodies induced by 
ROS-DNA were found to recognize native B, A and allied 
conforroations of DNA (Ara and Ali, 1993). 
It has been proposed that in SLE and other chronic 
inflammatory diseases, the phagocytic cells release oxygen 
species into the extracellular environment. These are highly 
reactive and penetrate cellular membranes, reacting with 
nuclear DNA (Joenje, 1989) causing damage to nucleic acid 
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(Schneider et al. , 1989). The ROS are known to induce 
conformational changes in DNA and also single and double 
stranded breaks (Halliwell and Aruotna, 1991) . Base damage 
and cross linking between cytosine and tyrosine in 
nucleohistone has also been reported (Dizdaroglu et al., 
1991). Release of the altered DNA may enable it to act as an 
antigen against which antibodies could be raisea. Thus, it 
appears that conformational variance from B-form is a 
prerequisite for the induction of antibody response, 
although the reason for this is not clear (Braun and Lee, 
1988) . 
Another characteristic feature of the disease is its 
high prevalence in female which is well documented (Lahita, 
1992) strongly suggesting that sex hormones influence 
disease activity. It has been suggested that the sex hormone 
estradiol and BSA in conjugation with DNA could form a 
possible antigenic trigger for SLE, which results in the 
production of autoantibodies highly specific towards the 
immunogen (Moinuddin and Ali, 1994) . Recently, it has been 
reported that ultraviolet-Al irradiation decreases clinical 
disease activity and autoantibodies in patients with SLE 
(McGrath, 1994) . Also, inhibition of autoantibody produc-
tion in experimental SLE can be achieved by pre-immuniza-
tion with DNA (Segal et al., 1994) . 
Modified nucleic acid polymers have been shown to be 
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immunogenic in contrast to native DNA which is a poor 
immunogen (Lafer et al., 1986). It has been observed that 
reactive oxygen species modified DNA is a better antigen 
for anti-DNA antibodies found in SLE sera (Blount et al, 
1990) . Experimentally induced antibodies against ROS 
modified DNA exhibit polyspecificity (Ara et al. , 1992; 
Alam et al., 1993) recognizing B, A, and allied conforma-
tions of deoxyribonucleic acids (Ara and Ali, 1993). 
In view of the observed antigenicity of ROS modified 
DNA, the present worJc was undertaJcen to probe the possible 
role of ROS-modified free DNA bases (adenine, thymine) and 
synthetic polymers (poly dA, polydT) in the etiology of 
autoimmune diseases, particularly SLE. 
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2. EXPERIMENTAL 
A. MATERIALS 
1. Chemicals 
Calf thymus DNA, nuclease S-^ (Aspergillus oryzae) , 
poly-L-lysine, poly-L-glutamate, bovine serum albumin, anti-
human IgG-alkaline phosphatase conjugate and thymine were 
obtained from Sigma Chemical Company, U.S.A. Folin-ciocalteu 
reagent and p-nitrophenyl phosphate were purchased from 
CSIR Centre for Biochemicals, New Delhi. Adenine was 
obtained from Merck, Germany. Hydrogen peroxide was 
purchased from Qualigens Fine Chemicals, Glaxo India Ltd. 
Synthetic polynucleotides poly (dA) and poly (dT) were 
obtained from Pharmacia Fine Chemicals, Sweden. Polystyrene 
microtitre flat bottom ELISA plates with 96 wells were 
purchased from Nunc, Denmark. 
2. Equipment 
Shimadzu s p e c t r o p h o t o m e t e r UV-240, ELISA m i c r o p l a t e 
Reader MR-600 (Dynatech, U.S.A.) , u l t r a v i o l e t lamp having 
maximum emiss ion a t 254 nm (Vi lber Lourmat, France) and 
E l ico pH meter were the major equipment used i n t h i s s tudy. 
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B. METHODS 
1. Purification of calf thymus DNA 
Calf thymus DNA obtained commercially was purified free 
of proteins, RNA and single stranded regions as described by 
Ali et al. (1985). The DNA (2 mg/ml) in 0.1 x SSC buffer 
(0.015 M sodium citrate, 0.15 M sodium chloride, pH 7.3) was 
mixed with an equal volume of chloroform : isoamyl alcohol 
mixture (24 : 1) in a stoppered measuring cylinder and 
shaken gently for an hour. The upper aqueous layer 
containing DNA was separated from organic layer. Extraction 
process with chloroform - isoamyl alcohol was repeated, 
after which the DNA was precipitated with two volumes of 
cold ethanol and collected on a glass rod. After drying, the 
DNA was redissolved in 30 mM acetate buffer, pH 5.0 
containing 30 mM ZnCl2- Subsequent treatment with nuclease 
S-L (200 units/mg DNA) at 37°C for 10 minutes removed the 
single stranded regions. The reaction was stopped by the 
addition of one tenth volume of 0.2 M EDTA, pH 8.0. The 
above solution was extracted with chloroform-isoamyl alcohol 
once again and precipitated with cold ethanol. Finally, the 
precipitate was dissolved in PBS (10 mM sodium phosphate, 
150 mM NaCl, pH 7.4). 
2. Coloriinetric Estimation of DNA 
The concentration of DNA was colorimetrically estimated 
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by the method of Burton (1956) using diphenylamine reagent. 
(a) Preparation of diphenylamine reagent 
750 mg of diphenylamine was mixed with 50 ml of glacial 
acetic acid containing 0.75 ml of concentrated sulphuric 
acid. This reagent was prepared immediately before use. 
(b) Procedure 
one millilitre of DNA solution was mixed with 1.0 ml of 
1 N perchloric acid and incubated for 15 minutes in a water 
bath at 70 ± 1°C. Next, hundred microlitre of 5.43 mM 
acetaldehyde was added, followed by the addition of 2.0 ml 
of freshly prepared diphenylamine reagent. The contents were 
mixed well and incubated at room temperature for 16-20 
hours. The absorbance was recorded at 600 nm and the DNA 
concentration in unknown sample was determined by 
constructing a standard plot using 0 - 100 )ig of purified 
native calf thymus DNA (Fig. 2 ) . 
3. Colorimetric Estimation o£ Protein 
Protein was colorimetrically estimated by the method of 
Lowry et al. (1951). 
(a) Folin-ciocalteu reagent 
This reagent was obtained from CSIR Centre for 
Biochemicals, New Delhi and was diluted 1 : 4 with distilled 
18 
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Figure 2. Standard plot for the colorimetric estimation of 
DNA. 
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water before use. 
(b) Alkaline copper reagent 
The components of this reagent are as follows : 
(i) 2% sodium carbonate in 0.1 N NaOH. 
(ii) 1% copper sulphate in 2% sodium potassium tartarate. 
The working reagent was freshly prepared by mixing 
components (i) and (ii) in a ratio of 50 : 1. 
(c) Procedure 
One millilitre of protein sample was mixed with 5.0 ml 
of alkaline copper reagent and allowed to stand at room 
temperature for 10 minutes. Then freshly prepared working 
Folin - Ciocalteu reagent (1 ml) was added and left at room 
temperature for 30 minutes. Subsequently absorbance was 
recorded at 660 nm. The concentration of protein in unknown 
sample was determined from a standard plot constructed by 
using varying concentrations of bovine serum albumin (Fig 3) 
4. Irradiation Procedure 
(a) Irradiation o£ DNA bases 
Adenine (7.4 mM) and thymine (3.97 mM) in PBS, pH 7.4 
were irradiated under 254 nm light for 30 minutes at room 
temperature in the presence of hydrogen peroxide. The bases 
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Figure 3. Standard plot for the colorimetric estimation of 
protein. 
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and hydrogen peroxide were taken in l : 10 molar ratio. Base 
samples exposed to hydrogen peroxide or UV light alone were 
used as controls. 
(b) Irradiation of synthetic polymers 
Poly (dA) and Poly (dT) [0.154 mM] in PBS, pH 7.4 were 
irradiated for 30 minutes with 254 nm light at room 
temperature in the presence of hydrogen peroxide. The molar 
ratio of the polymers and hydrogen peroxide was 1 : 10. 
5. Enzyme Linked Iimtivinosorbent Assay (ELISA) 
ELISA on flat bottom 96 well microtitre plates was 
performed according to the method of Aotsuka et al. (1979) 
with slight modification. 
(a) Buffers and reagents 
(i) Tris buffered saline (TBS), pH 7.4 
10 mM Tris, 150 mM NaCl, pH 7.4 
(ii) Tris-buffered saline Tween-20 (TBS-T), pH 7.4 
20mM Tris, 144 mM NaCl, 2.68 mM KCl and 500 ;al Tween-20 
per litre, 
(iii) Bicarbonate buffer, pH 9.6 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 2 
mM magnesium chloride, pH 9.6. 
(iv) Substrate 
Five hundred ^g/ml of p-nitrophenyl phosphate in 
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bicarbonate buffer, pH 9.6. 
(b) Procedure 
Polystyrene plates were preincubated with 100 >il poly-
D-lysine (50 >ig/ml in water) for 30 minutes at room 
temperature. The wells were washed three times with TBS, pH 
7.4, and thereafter coated wi^h 100 >il of nDNA antigen (2.5 
;ug/ml in TBS) for 2 hours at room temperature and overnight 
at 4'>C. The wells were emptied and washed three times with 
TBS-T, pH 7.4. Hundred microlitre of poly-L-glutamate (50 
p.g/ml in TBS) was added to antigen coated wells for 2 hours. 
After washing the wells three times with TBS-T, the 
unoccupied sites were blocked with 150 ;J1 of 1.5% BSA for 5-
6 hours at room temperature. Antibodies (100 _;al/well) to be 
tested (diluted in TBS) were adsorbed for 2 hours at room 
temperature and overnight at 4°C. The unbound material was 
removed by washing four times with TBS-T and twice with 
distilled water. Appropriate anti- immunoglobulin alkaline 
phosphatase conjugate was then added to each well. Finally 
the substrate, p-nitrophenyl phosphate was added and 
absorbance recorded at 410 nm on an automatic microplate 
reader after proper color development. Each sample was run 
in duplicate. The control wells were subjected to the same 
treatment but were devoid of antigen. Results were expressed 
as a mean of A^est-Acontrol • 
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6. Competition ELISA 
The specificity of the SLE autoantibodies was 
determined by competition ELISA using nDNA, ROS modified and 
unmodified bases (adenine, thymine) and ROS modified and 
unmodified polymers [poly (dA), poly (dT)] as inhibitors. 
Constant amount of SLE serum (1 : 100 dilution) was 
incubated with increasing amount? (0 - 20 ;ag) of the above 
mentioned inhibitors for 2 hours at room temperature and 
overnight at 4°C. The mixture was then added to antigen 
(nDNA) coated plates and the direct binding ELISA was 
performed. Each inhibitor dilution was run in duplicate and 
corrected for nonspecific reactivity in control wells. 
Percent inhibition was calculated using the formula : 
inhibition = x 100 
Ao 
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3. RESULTS 
Ultraviolet Irradiation and Spectroscopic Studies 
The bases (adenine, thymine) and their polymers [poly 
(dA) , poly (dT) ] were irradiated under 254 nm light for 30 
minutes at room temperature in the presence of hydrogen 
peroxide. Excess of hydrogen peroxide in the case of 
polymers was removed by extensive dialysis against PBS, pH 
7.4. The UV absorption spectra of the modified bases and 
polymers alongwith their corresponding controls were 
recorded to detect changes in their absorption profile 
(Figs. 4 to 7). Irradiation of bases alone or incubation 
with hydrogen peroxide without irradiation showed a minor 
decrease in absorption at 260 nm. This could be either due 
to the formation of respective dimers or other oxidation 
products. However, irradiation in the presence of hydrogen 
peroxide which is known to produce the most reactive of 
oxygen species, the hydroxyl radical, resulted in complete 
disappearance of characteristic absorption spectra. A 
generalised absorption getting stronger towards shorter wave 
length was observed. Almost similar changes were noted in 
case of adenine and thymine (Figs, 4 & 5). 
Interaction of poly (dA) with hydroxyl radical showed 
broadening of absorption maxima and drastic reduction in 
absorption at 260 nm. A slight shift of 10 nm in the 
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Figure 4. UV absorption spectra of native and ROS-modified 
adenine. 
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Figure 5. UV absorption spectra of native and ROS-modified 
thymine. 
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( ) Thymine + UV irradiation 
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Figure 7. UV absorption spectra of native and ROS-modified 
poly (dT). 
( ) Poly (dT) 
( ) Poly (dT) + hydrogen peroxide + 
UV irradiation 
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apparent minima from 230 nm to 240 nm (red shift) was also 
observed. In case of poly (dT) almost complete disappearance 
of absorption maxima in comparison to control sample was 
obtained. The modified poly (dT) showed almost no absorption 
from 230 to 300 nm. 
Antigenic Specificity o£ Anti-DNA Autoantibodies 
Three different SLE sera having high titer anti-native 
DNA autoantibodies were selected for this study. Their titer 
by direct binding ELISA using purified calf thymus DNA as 
antigen was > 1 : 12800, > 1 : 3200 and > 1 : 3200. The 
binding to native DNA was specific as high degree of inhibi-
tion was obtained with low concentration of n-DNA [Fig. 8]. 
The antigenic specificity of these antibodies was tested 
with adenine, thymine and poly (dA) , poly (dT) . These 
antigens were also modified with hydroxyl radial generated 
by UV exposure (254 nm) of their aqueous solutions in the 
presence of hydrogen peroxide. No inhibition of anti-DNA 
antibody binding to nDNA was observed with adenine, ROS-
modified adenine, poly (dA) and thymine (Figs. 9 to 12). 
Low level of inhibition was observed in case of ROS-modifed 
poly (dA) and unmodified poly (dT) (Figs. 13 and 14). 
However, high degree of inhibition was obtained with ROS-
modified thymine in all the three SLE sera tested (Fig. 15). 
Similarly, out of the three SLE sera, only one showed strong 
inhibition with ROS-modified poly (dT) (Fig. 16). 
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Figure 8. Inhibition of SLE anti-DNA antibody binding by 
native DNA. The microtitre plates were coated 
with native DNA (2.5 >ig/ml) 
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Figure 9 Inhibition of SLE anti-DNA antibody binding by 
adenine. The microtitre plates were coated witl'. 
native DNA (2 .5 jug/ml) 
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Figure 10 Inhibition of SLE anti-DNA antibody binding by 
ROS-modified adenine. The microtitre plates were 
coated with native DNA (2.5>ig/ml) . 
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Figure 11, Competition immunoassay of SLE anti-DNA antibody 
binding by poly (dA). The microtitre plates were 
coated with native DNA (2.5>ig/ml) 
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Figare 12. Competition immunoassay of SLE anti-DNA antibody 
binding by thymine. The microtitre plates were 
coated with native DNA (2.5jag/ml) 
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Figure 13 Competition inrounoassay of SLE anti-DNA antibody-
binding by ROS modified poly (dA). The microtitre 
plates were coated with native DNA (2.5 ;ug/ml). 
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Figure 14, Inhibition of SLE anti-DNA antibody binding by 
poly (dT). The microtitre plates were coated with 
native DNA (2.5 jag/tnl) 
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Figure 15. Inhibition of SLE anti-DNA antibody binding by 
ROS-modified thymine. The microtitre plates were 
coated with native DNA (2.5 ;ag/ml) . 
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Figure 16 Competition immunoassay of SLE anti-DNA antibody 
binding by ROS-modified poly (dT). The miorotitre 
plates were coated with native DNA (2.5jug/ml). 
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Analysis of the data showed that naturally occuring 
anti-DNA autoantibodies are specific toward native DNA as 
high level of inhibition was observed (Table 1) . Low 
concentration of nDNA (1.0 to 2.8 ;ag/ml) was required for 
the inhibition of 50 percent bindig to nDNA. Almost similar 
level of inhibition was found with ROS-modified thymine. In 
this case the concentration required to inhibit 50% binding 
of nDNA to anti-DNA antibodies varied from 9.0 ;ag/ml to 11.0 
_^g/ml, an increase of almost five fold. Neither poly (dA) 
nor its ROS-modified polymer showed any degree of inhibition 
in nDNA binding. However, poly (dT) and its modified form 
indicated various degrees of reactivity, which was different 
for each SLE sera. In all the three sera samples tested 50% 
inhibition could not be achieved. ROS-modified poly (dT) 
gave maximum inhibition of 57% and the concentration for 50% 
inhibition of nDNA binding to anti-DNA antibodies was found 
to be 1.4 ;ug/ml. 
The relative affinity of nDNA, ROS-thymine and ROS-poly 
(dT) is given in Table 2. Assuming the affinity of nDNA for 
the binding of anti-DNA antibodies to be 100 percent, ROS-
thymine showed an affinity of around 20 percent while in one 
of the SLE sera, ROS-poly (dT) indicated an affinity of 171 
percent. 
40 
TABLE 1 
Competitive Inhibition of Naturally Occurring 
SLE Anti-DNA Autoantibodies 
Inhibitor 
Concentration for 
50% Inhibition 
{>ig/ml) 
Maximum 
Percent 
Inhibition 
nDNA 
Adenine 
ROS-adenine 
Thymine 
ROS-thymine 
Poly (dA) 
ROS-poly (dA) 
Poly (dT) 
ROS-Poly (dT) 
2 . 8 2 .4 
1 1 . 0 1 0 . 5 
1.0 
9 . 0 
6 9 . 0 7 6 . 0 70 .0 
8.0 
1.4 
7 0 . 0 
1 2 . 0 
1 8 . 0 
1 7 . 0 
2 1 . 0 
6 6 . 0 
-
-
2 6 . 0 
5 7 . 0 
8 4 . 0 
8 . 0 
8 . 0 
4 8 . 0 
1 9 . 0 
1, 2 and 3 represent three d i f f e r en t SLE sera 
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TABLE 2 
Relative Binding Affinity of Anti-DNA Autoantibodies 
Inhibitor 
Concentration for 
50% Inhibition 
Oag/ml) 
Percent 
Relative 
Affinity 
nDNA 2.8 2.4 1.0 100.00 100.00 100.00 
ROS-thymine 11.0 10.5 9.0 25.45 22.85 11.11 
ROS-Poly (dT) 1.4 171.42 
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4. DISCUSSION 
In recent years there has been considerable interest on 
the damaging potential of reactive oxygen species (ROS) on 
living system (Halliwell, 1987) as important causative 
agents in the pathogenesis of several human degenerative 
diseases (Ames, 1983; Meneghini, 1988). Among the reactive 
intermediates hydroxyl radical is considered to be an 
extremely dangerous species reacting with a wide range of 
biological substances. The hydroxyl radicals are formed in 
biological systems via ionizing radiations or through the 
Haber - Weiss reaction (Mello - Filho and Meneghini, 1984). 
In chronic inflammatory disease, such as SLE activated 
phagocytes release large quantities of potentially damaging 
free radicals into the extracellular fluid. These free 
radicals cause degradation of DNA, which has been 
demonstrated by conformational changes (Allan et al., 1988), 
single stranded breaks (Ward et al., 1987) and the formation 
of altered bases (Lewis and Adams, 1985). It has been 
observed that hydroxyl radical predomin-antly modifies 
thymine residues (Hutchinson, 1985). 
Native DNA is a poor immunogen and antibodies are 
rarely induced upon immunization (Stollar, 1973). However, a 
number of synthetic analogues of DNA, its conformational 
variants and modified forms of nDNA have been shown to be 
potent immunogens (Stollar, 1989). It has been reported 
earlier that DNA upon exposure to 254 nm light in the 
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presence of hydrogen peroxide became highly immunogenic 
inducing high titre antibodies (Ara et al., 1992) which 
exhibited polyspecificity recognising the modified polymer, 
native B-conformation, A and allied conformations (Ara and 
Ali, 1993) . Hydrogen peroxide is a relatively stable oxidant 
and does not per se cause DNA damage, rather it is the 
precursor of a highly damaging reactant, which may be the 
hydroxyl radical that causes DNA damage. Exposure of DNA to 
UV light has significant consequence such as formation of 
photoproducts of purines and pyrimidines. The best 
characterized of these are the pyrimidine hydrates (Fisher 
and Johns, 1976a) and pyrimidine dimers (Fisher and Johns, 
1976b). 
In the present work, DNA bases adenine and thymine and 
synthetic polymers poly (dA) and poly (dT) were modified 
under 254 nm light in the presence of hydrogen peroxide. It 
was observed that adenine and thymine on exposure to UV 
light in the presence of hydrogen peroxide showed a drastic 
change in their absorption profile. This major change could 
be attributed to the extensive damage to the bases in the 
presence of hydrogen peroxide and UV light as UV light could 
cleave hydrogen peroxide to generate hydroxyl radical, which 
is a very powerful oxidant causing extensive base degra-
dation. Exposure of poly (dA) and poly (dT) to hydroxyl 
radical resulted in substantial decrease in UV absorbance at 
260 nm. UV light or hydrogen peroxide alone had almost no 
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effect under the present experimental condition. 
The hydroxyl radical modified bases and polymers were 
subsequently used as inhibitors of native DNA binding to 
human anti-DNA autoantibodies. It was observed that besides 
nDNA, modified thymine acted as an effective inhibitor 
showing upto 84% inhibition with one of the SLE serum. Some 
degree of inhihition was also seen with poly (dT) and RQS 
- poly (dT) . In contrast adenine and poly (dA) and their 
ROS-modified products did not show any apparent inhibition 
in antibody binding to nDNA. 
These studies point out the likelihood of thymine 
modification as a consequence of hydroxyl radical induced 
changes in native DNA. It is to point out that ROS-modified 
DNA has been shown to be a better antigen in the assay of 
anti-DNA antibodies (Blount et al., 1990) and the antibodies 
raised against ROS-DNA recognise nDNA (Ara et al., 1992). 
This is all the more important in view of the fact that 
native DNA is a poor antigen and does not induce antibodies 
against B-conformation. ROS-modified thymine in DNA might be 
responsible for the generation of unique conformation which 
could be the trigger for the induction of circulating 
antibodies cross reacting with nDNA, It appears that adenine 
has little or no role in the generation of these antibodies. 
Since cytosine and guanine have not been included in this 
study, it is difficult to comment on their involvement in 
the generation of anti-DNA autoantibodies. 
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